Cognitive disturbance in borderline personality disorder: Phenomenologic, social cognitive, and neurocognitive findings

Current Psychosis and Therapeutics Reports

Volumn 4, Issue 3, 2006, Pages 105-111

  Fertuck, Eric A ^a   Stanley, Barbara ^b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; LAMOTRIGINE; MOOD STABILIZER; OLANZAPINE; OMEGA 3 FATTY ACID; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; VALPROIC ACID;

BEHAVIOR THERAPY; BORDERLINE STATE; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISSOCIATIVE DISORDER; DRUG EFFICACY; FACIAL EXPRESSION; HUMAN; IMPULSIVENESS; INFORMATION PROCESSING; MAJOR DEPRESSION; MENTAL INSTABILITY; NEUROSCIENCE; PARANOIA; PHENOMENOLOGY; PSYCHOANALYSIS; PSYCHOSIS; PSYCHOTHERAPY; REVIEW; SEMI STRUCTURED INTERVIEW; SOCIAL PSYCHOLOGY; UNSPECIFIED SIDE EFFECT;

EID: 33845324132     PISSN: 15458083     EISSN: 15458091     Source Type: Journal    
DOI: 10.1007/BF02629331     Document Type: Review

References (58)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington, DC: American Psychiatric Association; 1994.
2. Gabbard G: Personality disorders come of age. Am J Psychiatry 2005, 162:833-835.
3. Lenzenweger MF: Stability and change in personality disorder features: the Longitudinal Study of Personality Disorders. Arch Gen Psychiatry 1999, 56:1009-1015.
4. Torgersen S, Kringlen E, Cramer V: The prevalence of personality disorders in a community sample. Arch Gen Psychiatry 2001, 58:590-596.
5. Paris J: Chronic suicidality among patients with borderline personality disorder. Psychiatr Serv 2002, 53:738-742.
6. Simeon D, Stanley B, Frances A, et al.: Self-mutilation in personality disorders: psychological and biological correlates. Am J Psychiatry 1992, 149:221-226.
7. Frankenburg FR, Zanarini MC: The association between borderline personality disorder and chronic medical illnesses, poor health-related lifestyle choices, and costly forms of health care utilization. J Clin Psychiatry 2004, 65:1660-1665.
8. Bender DS, Dolan RT, Skodol AE, et al.: Treatment utilization by patients with personality disorders. Am J Psychiatry 2001, 158:295-302.
9. Stiglmayr CE, Grathwol T, Linehan MM, et al.: Aversive tension in patients with borderline personality disorder: a computer-based controlled field study. Acta Psychiatr Scand 2005, 111:372-379.
10. • Kernberg OF: A psychoanalytic theory of personality disorders. In Major Theories of Personality Disorder. Edited by Clarkin JF, Lenzenweger MF. New York: Guilford; 1996:106-140. A description of cognitive difficulties within a psychoanalytic framework.
11. •• Zanarini MC, Gunderson JG, Frankenburg FR: Cognitive features of borderline personality disorder. Am J Psychiatry 1990, 147:57-63. A study that documented the importance of quasi-psychotic thought in BPD leading to revision of the diagnostic criteria in the DSM-IV.
12. Lenzenweger MF, Cornblatt BA, Putnick M: Schizotypy and sustained attention. J Abnorm Psychol 1991, 100:84-89.
13. Roitman SE, Cornblatt BA, Bergman A, et al.: Attentional functioning in schizotypal personality disorder. Am J Psychiatry 1997, 154:655-660.
14. Meares R, Stevenson J, Gordon E: A Jacksonian and biopsychosocial hypothesis concerning borderline and related phenomena. Aust N Z J Psychiatry 1999, 33:831-840.
15. Heard JH, Startup M, Swales M, et al.: Autobiographical memory and dissociation in borderline personality disorder. Psychol Med 1999, 29:1397-1404.
16. Cloitre M, Cancienne J, Brodsky B, et al.: Memory performance among women with parental abuse histories: enhanced directed forgetting or directed remembering? J Abnorm Psychol 1996, 105:204-211.
17. • Fonagy P, Leigh T, Steele M, et al.: The relation of attachment status, psychiatric classification, and response to psychotherapy. J Consult Clin Psychol 1996, 64:22-31. A study that documented impairments in mentalization and reflective function in persons who report early trauma.
18. Koerner K, Linehan MM: Research on dialectical behavior therapy for patients with borderline personality disorder. Psychiatr Clin North Am 2000, 23:151-167.
19. Nigg JT, Silk KR, Westen D, et al.: Object representations in the early memories of sexually abused borderline patients. Am J Psychiatry 1991, 148:864-869.
20. Segal H, Westen D, Lohr NE, Silk KR: Clinical assessment of object relations and social cognition using stories told to the picture arrangement subtest of the WAIS-R. J Pers Assess 1993, 61:58-80.
21. Hupricha SK, Greenberg RP: Advances in the assessment of object relations in the 1990s. Clin Psychol Rev 2003, 23:665-698.
22. Arntz A, Veen G: Evaluations of others by borderline patients. J Nerv Ment Dis 2001, 189:513-521.
23. Veen G, Arntz A: Multidimensional dichotomous thinking characterizes borderline personality disorder. Cogn Ther Res 2000, 24:23-45.
24. Cohen BD, Gara MA: Self-structure in borderline personality disorder. Am J Orthopsychiatry 1992, 62:618-625.
25. Robey KL, Cohen BD, Gara MA: Self-structure and schizophrenia. J Abnorm Psychol 1989, 98:436-442.
26. Clarkin JF, Foelsch PA, Levy KN, et al.: The development of a psychodynamic treatment for patients with borderline personality disorder: a preliminary study of behavioral change. J Personal Disord 2001, 15:487-495.
27. Young JE: Cognitive Therapy for Personality Disorders: A Schema-focused Approach. Sarasota, FL: Professional Resource Press; 1999.
28. Arntz A, Dietzel R, Dreessen L.: Assumptions in borderline personality disorder: specificity stability and relationship with etiological factors. Beh Res Ther 1999, 37:545-557.
29. Beck AT, Butler AC, Brown GK, et al.: Dysfunctional beliefs discriminate personality disorders. Behav Res Ther 2001, 39:1213-1225.
30. Butler A, Brown GK, Beck AT, Grisham JR: Assessment of dysfunctional beliefs in borderline personality disorder. Behav Res Ther 2002, 40:1231-1240.
31. Ekman P, Sorenson ER, Friesen WV: Pan-cultural elements in facial displays of emotions. Science 1969, 164:86-88.
32. Levine D, Marziali E, Hood J: Emotion processing in borderline personality disorders. J Nerv Ment Dis 1997, 185:240-246.
33. Wagner A, Linehan MM: Facial expression recognition ability among women with borderline personality disorder: implications for emotion regulation? J Personal Disord 1999, 13:329-344.
34. Meyer B, Pilkonis PA, Beevers CG: What's in a (neutral) face? Personality disorders, attachment styles, and the appraisal of ambiguous social cues. J Personal Disord 2004, 18:320-336.
35. •• Donegan NH, Sanislow CA, Blumberg HP, et al.: Amygdala hyperreactivity in borderline personality disorder: implications for emotional dysregulation. Biol Psychiatry 2003, 54:1284-1293. Neuroimaging study that documents great amygdala activation to faces in BPD versus controls.
36. Pollak S, Kistler DJ: Early experience is associated with the development of categorical representations for facial expressions of emotion. Proc Natl Acad Sci U S A 2002, 99:9072-9076.
37. Niedenthal P, Brauer M, Robin L, Innes-Ker AH: Adult attachment and the perception of facial expression of emotion. J Pers Soc Psychol 2002, 82:419-33.
38. •• Fertuck EA, Lenzenweger MF, Clarkin JF, et al.: Executive neurocognition, memory systems, and borderline personality disorder. Clin Psychol Rev 2006, 26:346-375. A comprehensive review of neurocognition in BPD.
39. Bazanis E, Rogers RD, Dowson JH, et al.: Neurocognitive deficits in decision-making and planning of patients with DSM-III-R borderline personality disorder. Psychol Med 2002, 32:1395-1405.
40. Lenzenweger MF, Clarkin JF, Fertuck EA, Kernberg OF: Executive neurocognitive functioning and neurobehavioral systems indicators in borderline personality disorder: a preliminary study. J Personal Disord 2004, 18:421-438.
41. Posner MI, Rothbart MK, Vizueta N, et al.: Mechanisms of borderline personality disorder. Proc Natl Acad Sci U S A 2002, 99:16366-16370.
42. Fertuck EA, Marsano-Jozefowicz S, Stanley B, et al.: The impact of anxiety and borderline personality disorder on neuropsychological performance in major depression. J Personal Disord 2006, 20:55-70.
43. Hochhausen NM, Lorenz AR, Newman JP: Specifying the impulsivity of female inmates with borderline personality disorder. J Abnorm Psychol 2002, 111:495-501.
44. Leyton M, Okazawa H, Diksic M, et al.: Brain regional alpha-[11C] methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder. Am J Psychiatry 2001, 158:775-782.
45. Korfine L, Hooley JM: Directed forgetting of emotional stimuli in borderline personality disorder. J Abnorm Psychol 2000, 109:214-221.
46. • Ochsner KN, Gross JJ: The cognitive control of emotion. Trends Cogn Sci 2005, 9:242-249. A review of cognitive neuroscience findings in emotion regulation and cognitive control.
47. Fan J, McCandliss BD, Sommer T, et al.: Testing the efficiency and independence of attentional networks. J Cog Neurosci 2002, 3:340-347.
48. Trull TJ: Structural relations between borderline personality disorder features and putative etiological correlates. J Abnorm Psychol 2001, 110:471-481.
49. Keilp JG, Sackeim H, Mann JJ: Correlates of trait impulsiveness in performance on neuropsychological tests. Psychiatry Res 2005, 135:191-201.
50. Soloff PH: Psychopharmacology of borderline personality disorder. Psychiatr Clin North Am 2000, 23:169-192.
51. Zanarini MC, Frankenburg FR: Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebocontrolled pilot study. J Clin Psychiatry 2001, 62:849-854.
52. Rinne T, van den Brink W, Wouters L, van Dyck R: SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. Am J Psychiatry 2002, 159:2048-2054.
53. Hollander E, Swann AC, Coccaro EF, et al.: Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. Am J Psychiatry 2005, 162:621-624.
54. Loew T, Nickel MK, Muehlbacher M, et al.: Topiramate treatment for women with borderline personality disorder: a double-blind, placebo-controlled study. J Clin Psychopharmacol 2006, 26:61-66.
55. Nickel M, Nickel C, Kaplan P, et al.: Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study. Biol Psychiatry 2005, 57:495-499.
56. Nickel M, Muehlbacher M, Nickel C, et al.: Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study. Am J J Psychiatry 2006, 163:833-838.
57. Tritt K, Nickel C, Lahmann C, et al.: Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study. J Psychopharmacol 2005, 19:287-291.
58. Zanarini MC, Frankenburg FR: Omega-3 fatty acid treatment of women with borderline personality disorder: a double-blind, placebo controlled pilot study. Am J Psychiatry 2003, 160:167-169.